aTyr Pharma (LIFE) Tops Q2 EPS by 6c

August 10, 2016 4:15 PM EDT
Get Alerts LIFE Hot Sheet
Trade LIFE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.65), $0.06 better than the analyst estimate of ($0.71).

Financial Guidance

As of June 30, 2016, we had $96.6 million in cash, cash equivalents and investments and 23.7 million shares of common stock outstanding.

We currently expect that our cash, cash equivalents and investments will be sufficient to fund our anticipated operations into 2018.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment